EUVIMEDEUVIMED entdecken
Crossref

LC-MS/MS method for quantification of 23 TKIs in Plasma: Assessing the relationship between anlotinib trough concentration and toxicities

Chen Bu, Liansheng Jiang, Lili Cui, Mao Tang, Xinhua Song, Yingkui Zhao, Zhengyan Liang, Liya Ye, Jiayao Nian, Shouhong Gao, Xia Tao, Zhipeng Wang und 1 weitere

Clinica Chimica Acta · 2025

DOI: 10.1016/j.cca.2024.120028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinica Chimica Acta, 2025. Verfasst von Chen Bu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Second Affiliated Hospital of Naval Medical University, Shanghai 200003, China. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Quinolines, Indoles, Protein Kinase Inhibitors. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: To develop a simple, rapid, and sensitive LC-MS/MS method for quantifying 23 tyrosine kinase inhibitors (TKIs) in plasma samples, and evaluate the relationship between the trough concentration of anlotinib(ANL) and its toxicities. METHODS: The method was developed in Agilent 1290-6460 UHPLC-MS/MS system. This study prospectively enrolled 55 cancer patients undergoing ANL treatment. Plasma samples were collected at steady-state trough concentration and subsequently analyzed using the method. Patients were recorded for the occurrence of toxicities. Statistical analysis was performed to assess the association of the toxicities with ANL exposure level and patients' characteristics. RESULTS: The LC-MS/MS method was developed and validated for all items required by pharmacopoeia. The results revealed a positive association between the trough concentration of ANL and the incidence of toxicities. The exposure level 17.655 ng/mL (AUC 0.82, p = 0.010) was identified as a predictive threshold value for grade ≥ 3 overall toxicities. In addition, lower platelet count (PLT count < 179 × 109 g/L) was significantly associated with higher occurrence of grade ≥ 3 toxicities (AUC 0.75, p = 0.049). A logistic model incorporating these two factors demonstrated improved diagnostic capacity for predicting ≥ 3 overall toxicities (AUC = 0.90, p = 0.001). CONCLUSIONS: This study successfully developed and validated a simple, rapid, and sensitive LC-MS/MS method for quantifying 23 TKIs in plasma samples. Besides, this study found that both Ctrough of ANL and PLT count as independent predictors for ANL-induced ≥ 3 overall toxicities. Moreover, a logistic model including these two factors presents better prediction capacity for ≥ 3 overall toxicities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tandem Mass SpectrometryQuinolinesIndolesProtein Kinase InhibitorsHumansMaleFemaleMiddle AgedAgedAdultChromatography, High Pressure LiquidNeoplasmsChromatography, LiquidAntineoplastic AgentsLiquid Chromatography-Mass Spectrometry

Stichwörter der Autor:innen

AnlotinibCancerLC-MS/MSToxicitiesTrough concentration

Substanzen

QuinolinesanlotinibIndolesProtein Kinase InhibitorsAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Pharmacy, Second Affiliated Hospital of Naval Medical University, Shanghai 200003, China.
  • Department of Laboratory Medicine, Second Affiliated Hospital of Naval Medical University, Shanghai 200003, China.
  • College of Traditional Chinese Medicine, Yunnan University of Traditional Chinese Medicine, Kunming, Yunnan 650500, China.
  • Department of Pharmacy, Second Affiliated Hospital of Naval Medical University, Shanghai 200003, China. Electronic address: gaoshouhong@smmu.edu.cn.
  • Department of Pharmacy, Second Affiliated Hospital of Naval Medical University, Shanghai 200003, China. Electronic address: taoxia@smmu.edu.cn.
  • Department of Pharmacy, Second Affiliated Hospital of Naval Medical University, Shanghai 200003, China. Electronic address: wangzhipeng@smmu.edu.cn.

Zitieren

APA

Bu, C., Jiang, L., Cui, L., Tang, M., Song, X., Zhao, Y., Liang, Z., Ye, L., Nian, J., Gao, S., Tao, X., Wang, Z., & Chen, W. (2025). LC-MS/MS method for quantification of 23 TKIs in Plasma: Assessing the relationship between anlotinib trough concentration and toxicities. Clinica Chimica Acta. https://doi.org/10.1016/j.cca.2024.120028

Vancouver

Bu C, Jiang L, Cui L, Tang M, Song X, Zhao Y, et al. LC-MS/MS method for quantification of 23 TKIs in Plasma: Assessing the relationship between anlotinib trough concentration and toxicities. Clinica Chimica Acta. 2025. doi:10.1016/j.cca.2024.120028

BibTeX
@article{Bu2025,
  author = {Bu, Chen and Jiang, Liansheng and Cui, Lili and Tang, Mao and Song, Xinhua and Zhao, Yingkui and Liang, Zhengyan and Ye, Liya and Nian, Jiayao and Gao, Shouhong and Tao, Xia and Wang, Zhipeng and Chen, Wansheng},
  title = {LC-MS/MS method for quantification of 23 TKIs in Plasma: Assessing the relationship between anlotinib trough concentration and toxicities},
  journal = {Clinica Chimica Acta},
  year = {2025},
  doi = {10.1016/j.cca.2024.120028}
}
Kostenlos starten →